SCHEMBL6325644

SCHEMBL6325644

COc1ccc(-c2noc(CCC(=O)O)n2)c(OC)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.68
ATM Q13315 1/20 0.68
ALDH1A1 P00352 8/20 0.59
TP53 P04637 4/20 0.59
MITF O75030 1/20 0.56
NCOA3 Q9Y6Q9 1/20 0.56
MAPT P10636 8/20 0.55
HPGD P15428 3/20 0.55
TSHR P16473 2/20 0.55
FFAR1 O14842 1/20 0.53
HTT P42858 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KDM4E B2RXH2 2/20 0.53
GAA P10253 2/20 0.52
HSD17B10 Q99714 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALOX15 P16050 1/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325724 0.91 LMNA (0.68) LMNAATMALDH1A1TP53MITF
SCHEMBL333242 0.87 LMNA (0.67) LMNAATMALDH1A1TP53MITF
SCHEMBL6328368 0.84 ALDH1A1 (0.67) LMNAATMALDH1A1TP53MAPT
SCHEMBL1567346 0.81 LMNA (1.00) LMNAATMALDH1A1TP53MITF
SCHEMBL6324681 0.80 FFAR1 (0.75) LMNAATMALDH1A1TP53MITF
SCHEMBL6325652 0.79 LMNA (0.64) LMNAATMALDH1A1TP53MITF
SCHEMBL6327249 0.79 LMNA (0.76) LMNAATMALDH1A1TP53MITF
SCHEMBL6331512 0.79 LMNA (0.58) LMNAATMALDH1A1TP53MITF
SCHEMBL7944909 0.78 LMNA (0.64) LMNAATMALDH1A1TP53MITF
SCHEMBL3046287 0.76 L3MBTL1 (0.62) LMNAATMALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423120-A4 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORP (US) 2005-12-28 EP disclosed
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed
EP-1423120-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2004-06-02 EP disclosed
US-20040087588-A1 Parp inhibitors ICOS CORPORATION 2004-05-06 US disclosed
WO-2003015785-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087588-A1 Parp inhibitors PARP1, PARP2, PARP11 LMNA 448/4885ATM 414/4885ALDH1A1 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.